Food and Drug Administration (FDA)
5600 Fishers Lane
Rockville
Maryland
20857
United States
Tel: 888-463-6332 or 1-888-INFO-FDA (1-888-463-6332)
Website: http://www.fda.gov/
About Food and Drug Administration (FDA)
FDA Overview:
The Food and Drug Administration is one of the nation's oldest and most respected consumer protection agencies. This presentation will tell you about FDA's responsibilities, the tools we use to fulfill those responsibilities, and our priorities for improving the way we serve the public.
•Stated most simply, FDA's mission is:
- to promote and protect the public health by helping safe and effective products reach the market in a timely way,
- To monitor products for continued safety after they are in use, and
- To help the public get the accurate, science-based information needed to improve health.
FDA's Mission Statement
The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.
26341 articles about Food and Drug Administration (FDA)
-
FDA Receives Over-The-Counter WayPoint Biomedical, Inc. And CLIA Waived Clearance For Health Essist(R) Marijuana & Cocaine And Multi-Drug Cup Home Drug Tests
8/29/2006
-
The Day In Review: FDA Pays $500 Million For Cancer Drug
8/28/2006
-
Pharmatech President To Instruct At PDA/FDA Joint Regulatory Conference; Focus On Six Sigma And Risk Management In Drug Development Lifecycle
8/28/2006
-
InSite Vision Announces FDA Acceptance Of New Drug Application For Review
8/28/2006
-
FDA Staff Question Adeza Biomedical's Pre-Term Birth Drug
8/28/2006
-
FDA Release: COLAZAL(R) Pediatric Exclusivity Granted
8/28/2006
-
EPIX Pharmaceuticals Receives Response From The FDA Regarding Appeal Of Vasovist(TM) Approvable Letters
8/28/2006
-
Cardinal Health, Inc. Suspends Production Of Alaris SE Infusion Pump Following FDA Actions
8/28/2006
-
Stryker Corporation Receives FDA Clearance For LFIT(TM) Anatomic Femoral Heads With X3(R) Liners
8/25/2006
-
FDA Cash Reserves $25.4M, Phenoxodiol Receives US Novogen Limited Clearance For Phase III Human Trial
8/25/2006
-
FDA Allows Easier Access To "Morning-After" Pill; Advocates Want More Plan B Pill Access
8/25/2006
-
FDA Advisory Panel Recommends Approval Of BioForm Medical, Inc.'s RADIESSE(R) For Two Facial Aesthetic Applications
8/25/2006
-
FDA Oks GE Healthcare, Volcano Corporation Imaging System
8/24/2006
-
FDA Grants OTC Status To Barr Pharmaceuticals, Inc.'s Plan B(R) Emergency Contraceptive
8/24/2006
-
Dendreon Corporation Submits Clinical And Non-Clinical Sections Of Rolling BLA To FDA For PROVENGE To Treat Advanced Prostate Cancer Patients
8/24/2006
-
Biovail Corporation Commences Legal Action To Enforce Criteria Set Forth In Its Citizen Petition
8/24/2006
-
Theratechnologies Inc. Receives Special Protocol Assessment From FDA For Second Pivotal Phase 3 Trial With TH9507
8/23/2006
-
Questcor Pharmaceuticals, Inc. (Headquarters) Files sNDA For Treatment Of Infantile Spasms With H.P. Acthar(R) Gel; FDA Accepts Application For Review
8/23/2006
-
Merck & Co., Inc. Provides Preliminary Analyses Of The Completed MEDAL Program For ARCOXIA(TM) (Etoricoxib)
8/23/2006
-
Impliant Ltd. Receives FDA Approval To Begin Pivotal Clinical Trial For Patented TOPS(TM) System
8/23/2006